- GRI Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
GRI Bio (GRI) 8-K14 Aug 23On track to launch a Phase 2a biomarker study evaluating GRI-0621 for the treatment of IPF before year end 2023Financial data
Company Profile